Evaluation of versant hepatitis C virus genotype assay (LiPA) 2.0

Journal of Clinical Microbiology

Volumn 46, Issue 6, 2008, Pages 1901-1906

  Verbeeck, Jannick ^a   Stanley, Mark J ^b   Shieh, Jen ^b   Celis, Linda ^c   Huyck, Els ^c   Wollants, Elke ^a   Morimoto, Judy ^b   Farrior, Alice ^b   Sablon, Erwin ^c   Jankowski Hennig, Margaret ^d   Schaper, Carl ^d   Johnson, Pamela ^d   Van Ranst, Marc ^a   Van Brussel, Marianne ^c  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

^b KAISER PERMANENTE   (United States)

^c INNOGENETICS   (Belgium)

^d Siemens Healthcare Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

5' UNTRANSLATED REGION; ACCURACY; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; GENE SEQUENCE; GENOTYPE; HEPATITIS C VIRUS; NONHUMAN; PRIORITY JOURNAL; PROCESS DEVELOPMENT; RELIABILITY; REPRODUCIBILITY; SAMPLE; SENSITIVITY ANALYSIS; VERSANT HEPATITIS C VIRUS GENOTYPE ASSAY; VIRUS EXAMINATION; VIRUS TYPING;

5' UNTRANSLATED REGIONS; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HUMANS; NUCLEIC ACID HYBRIDIZATION; REAGENT KITS, DIAGNOSTIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; TIME FACTORS; VIRAL CORE PROTEINS;

HEPATITIS C VIRUS;

EID: 45149105859     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02390-07     Document Type: Article

References (34)

1. Andonov, A., and R. K. Chaudhary. 1995. Subtyping of hepatitis C virus isolates by a line probe assay using hybridization. J. Clin. Microbiol. 33:254-256.
2. Ansaldi, F., F. Torre, B. M. Bruzzone, A. Picciotto, P. Crovri, and G. Icardi. 2001. Evaluation of a new hepatitis C virus sequencing assay as a routine method for genotyping. J. Med. Virol. 63:17-21.
3. Bell, H., K. Hellum, S. Harthug, A. Maeland, S. Ritland, B. Myrvang, B. von der Lippe, N. Raknerud, K. Skaug, B. G. Gutigard, R. Skjaerven, L. E. Prescott, P. Simmonds, et al. 1997. Genotype, viral load and age as independent predictors of treatment outcome of interferon-alpha 2a treatment in patients with chronic hepatitis C. Scand. J. Infect. Dis. 29:17-22.
4. Chen, Z., and K. E. Week. 2002. Hepatitis C virus genotyping: interrogation of the 5′ untranslated region cannot accurately distinguish genotypes 1a and lb. J. Clin. Microbiol. 40:3127-3134.
5. Chinchai, T., J. Labout, S. Noppornpanth, A. Theamboonlers, B. L. Haagmans, A. Osterhaus, and Y. Poovorawan. 2003. Comparative study of different methods to genotype hepatitis C virus type 6 variants. J. Virol. Methods 109:195-201.
6. Germer, J. J., P. N. Rys, J. N. Thorvilson, and D. H. Persing. 1999. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J. Clin. Microbiol. 37:2625-2630.
7. Halfon, P., A. U. Neumann, M. Bourliere, A. Rieu, S. Chadapaud, H. Khiri, Ouzan, D., and P. Cacoub. 2003. Slow viral dynamics of hepatitis C virus genotype 4. J. Viral Hepat. 10:351-353.
8. Halfon, P., P. Trimoulet, M. Bourliere, H. Khiri, V. De Ledinghen, P. Couzigou, J. M. Feryn, P. Alcaraz, C. Renou, H. J. Fleury, and D. Ouzan. 2001. Hepatitis C virus genotyping based on 5′ noncoding sequence analysis (Trugene). J. Clin. Microbiol. 39:1771-1773.
9. Haushofer, A. C., J. Berg, R. Hauer, D. Trubert-Exinger, H. G. Stekel, and H. H. Kessler. 2003. Genotyping of hepatitis C virus - comparison of three assays. J. Clin. Virol. 27:276-285.
10. Jiao, J., and J. B. Wang. 2005. Hepatitis C virus genotypes, HLA-DRB alleles and their response to interferon-alpha and ribavirin in patients with chronic hepatitis C. Hepatobiliary Pancreat. Dis. Int. 4:80-83.
11. Koike, K. 2006. Antiviral treatment of hepatitis C: present status and future prospects. J. Infect. Chemother. 12:227-232.
12. Lee, J. H., W. K. Roth, and S. Zeuzem. 1997. Evaluation and comparison of different hepatitis C virus genotyping and serotyping assay. J. Hepatol. 26: 1001-1009.
13. Legrand-Abravanel, F., K. Sandres-Saune, K. Barange, L. Alric, J. Moreau, P. Desmorat, J. P. Vinel, and J. Isopet. 2004. Hepatitis C virus genotype 5: epidemiological characteristics and sensitivity to combination therapy with interferon-alpha plus ribavirine. J. Infect. Dis. 189:1397-1400.
14. Medeiros-Filho, J. E., I. M. de Carvalho Mello, J. R. Pinho, A. U. Neumann, F. de Mello Malta, L. C. da Silva, and F. J. Carrilho. 2006. Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapy. World J. Gastroenterol. 12:7271-7277.
15. Moradpour, D., A. Cerny, and M. H. Hein. 2001. Hepatitis C: an update. Swiss Med. Wkly. 131:291-298.
16. National Institutes of Health. 2002. National Institutes of Health consensus development conference statement: management of hepatitis C. 2002. - June 10-12, 2002. Hepatology 36:S3-S15.
17. Neumann, A. U., N. P. Lam, H. Dahari, M. Davidian, T. E. Wiley, B. P. Mika, A. S. Perelson, and T. J. Layden. 2000. Differences in viral dynamics between genotypes 1 and 2 of hepatitis C virus. J. Infect. Dis. 182:28-35.
18. Nguyen, M. H., and E. B. Keeffe. 2005. Prevalence and treatment of hepatitis C virus genotypes 4, 5 and 6. Clin. Gastroenterol. Hepatol. 3:S97-S101
19. Nolte, F. S., A. M. Green, K. R. Fiebelkorn, A. M. Caliendo, C. Sturchio, A. Grunwald, and M. Healy. 2003. Clinical evaluation of two methods for genotyping hepatitis C virus based on analysis of the 5′ noncoding region. J. Clin. Microbiol. 41:1558-1564.
20. Noppornpanth, S., E. Sablon, K. De Nys, X. L. Truong, J. Brouwer, M. Van Brussel, S. L. Smits, Y. Poovorawan, A. D. Osterhaus, and B. L. Haagmans. 2006. Genotyping of hepatitis C viruses from Southeast Asia by a novel line probe assay that simultaneously detects core and 5′ untranslated regions. J. Clin. Microbiol. 44:3969-3974.
21. Pawlotsky, J. M. 2003. Hepatitis C virus genetic variability: pathogenic and clinical implications. Clin. Liver Dis. 7:45-66.
22. Pawlotsky, J. M. 2003. Mechanisms of antiviral treatment efficacy and failure in chronic hepatitis C. Antiviral Res. 59:1-11.
23. Richter, S. S. 2002. Laboratory assays for diagnosis and management of hepatitis C virus infection. J. Clin. Microbiol. 40:4407-4412.
24. Seeff, L. B., and J. H. Hoofnagle. 2002. National Institutes of Health consensus development conference: management of hepatitis C: 2002. Hepatology 36:S1-S2.
25. Simmonds, P., A. Alberti, H. J. Alter, F. Bonino, D. W. Bradley, C. Bechot, J. T. Brouwer, S. W. Chan, K. Chayama, D. S. Chen, Q. L. Choo, M. Colombo, H. T. M. Cuypers, T. Date, G. M. Dusheiko, J. I. Esteban, O. Fay, S. J. Hadziyannis, J. Han, A. Hatzakis, E. C. Holmes, H. Hotta, M. Houghton, B. Irvine, M. Kohara, J. A. Kolberg, G. Kuo, J. Y. N. Lau, P. N. Lelie, G. Maertens, F. McOmish, T. Miyamura, M. Mizokami, A. Nomoto, A. M. Prince, H. W. Reesink, C. Rice, M. Roggendorf, S. W. Schalm, T. Shikata, K. Shimotohno, L. Stuyver, C. Trépo, A. Weiner, P. L. Yap, and M. S. Urdea. 1994. A proposed system for the nomenclature of hepatitis C viral genotypes. Hepatology 19:1321-1324.
26. Simmonds, P., J. Bukh, C. Combet, G. Deleage, N. Enomoto, S. Feinstone, P. Halfen, G. Inchauspé, C. Kuiken, G. Maertens, M. Mizokami, D. G. Murphy, H. Okamoto, J. M. Pawlotsky, F. Penin, E. Sablon, I. T. Shin, L. J. Stuyver, H. J. Thiel, S. Viazov, A. J. Weiner, and A. Windell. 2005. Consensus proposal for a unified system of nomenclature of hepatitis C virus genotypes. Hepatology 42:962-973.
27. Simmonds, P., E. C. Holmes, T. A. Cha, S. W. Chan, F. McOmish, B. Irvine, E. Beall, P. L. Yap, J. Kolberg, and M. S. Urdea. 1993. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS5 region. J. Gen. Virol. 74:2391-2399.
28. Smith, D. B., J. Mellor, L. M. Jarvis, F. Davidson, J. Kolberg, M. Urdea, P. L. Yap, and P. Simmonds. 1995. Variation of the hepatitis C virus 5′ non-coding region: implications for secondary structure, virus detection and typing. J. Gen. Virol. 76:1749-1761.
29. Stuyver, L., A. Wyseur, W. Van Arnhem, F. Hernandez, and G. Maertens. 1996. Second-generation line probe assay for hepatitis C virus genotyping. J. Clin. Microbiol. 34:2259-2266.
30. Tang, S., I. K. Cheng, V. K. Leung, U. I. Kuok, A. W. Tang, Y. Wing Ho, K. Neng Lai, and T. Mao Chan. 2003. Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin. J. Hepatol. 39:875-878.
31. Verbeeck, J., P. Maes, P. Lemey, O. G. Pybus, E. Wollants, P. Song, F. Nevens, J. Févery, W. Delport, S. Van der Merwe, and M. Van Ranst. 2006. Investigating the origin and spread of hepatitis C virus genotype 2a. J. Virol. 80:4220-4226.
32. Week, K. 2005. Molecular methods of hepatitis C genotyping. Expert Rev. Mol. Diagn. 5:507-520.
33. World Health Organization. 1999. Global surveillance and control of hepatitis C. Report of a WHO consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral Hepatol. 6:35-47.
34. World Health Organization. 2007. Initiative for vaccine research. http://www.who.int/vaccine_research/diseases/viral_cancers/en/index2.html.